Navigation Links
Texas Children's Hospital is first in North America to own Leica Microsystems Gated Stimulation Emission Depletion microscope
Date:8/20/2012

HOUSTON, Aug. 20, 2012 /PRNewswire-USNewswire/ -- Texas Children's Hospital is the first institution in North America to acquire a Leica Microsystems Gated Stimulation Emission Depletion (G-STED) microscope. The new microscope allows researchers to take never before seen, super-resolution photos below 40 nanometers within a cell and is the only microscope in the world that can acquire images at this level of resolution from deep within cells and from within living cells. Learn more about Immunology, Allergy and Rheumatology at Texas Children's Hospital.

(Photo: http://photos.prnewswire.com/prnh/20120820/DC60011)

This microscope will enable researchers at Texas Children's to see interactions that are taking place at a cellular level, within live cells, to better understand and gain new insights into congenital immune deficiencies and immune defenses which can lead to novel therapy approaches. It will also aid researchers in understanding the mechanics and interactions of viruses within a cell and provide never before gleaned detailed information about how infections occur.

"Leica's G-STED microscope allows us to have unprecedented views into the human immune system which is especially relevant in helping us explore extremely rare immune deficiencies in children," said Dr. Jordan Orange, chief of Immunology, Allergy and Rheumatology and director of a new Center for Human Immunobiology at Texas Children's Hospital, as well as professor and section head for Immunology, Allergy and Rheumatology in the department of pediatrics at Baylor College of Medicine. "This microscope will empower us to obtain deep mechanistic insights into the human immune system and visually observe the ramifications when those mechanisms go wrong. This will ultimately benefit our patients as we push beyond the current treatment options and find novel therapies for a variety of illnesses by better understanding the human immune system."

Orange's research focuses on the biology of natural killer cells and the innate immune system, with a clinical focus on primary immunodeficiency disease. He has received funding from the National Institute of Allergy and Infectious Diseases, as well as the United States Immunodeficiency Network to support his laboratory work.

Over the past decade, Orange has invigorated the field of human natural killer cell deficiencies in various genetic disorders. He recently collaborated with European researchers who achieved marked clinical improvements in using gene therapy to treat young children with Wiskott-Aldrich syndrome, a rare but often severe immunodeficiency disorder. He is currently conducting clinical trials testing the use of immunotherapy to boost immune function in children with Wiskott-Aldrich syndrome. His use of advanced imaging technologies has enabled otherwise impossible insights into these rare diseases and overall into human immune defenses.

About Texas Children's Hospital

Texas Children's Hospital, a not-for-profit organization, is committed to creating a community of healthy children through excellence in patient care, education and research. Consistently ranked among the top children's hospitals in the nation, Texas Children's has recognized Centers of Excellence in multiple pediatric subspecialties including the Cancer and Heart Centers, and operates the largest primary pediatric care network in the country. Texas Children's has completed a $1.5 billion expansion, which includes the Jan and Dan Duncan Neurological Research Institute; Texas Children's Pavilion for Women, a comprehensive obstetrics/gynecology facility focusing on high-risk births; and Texas Children's Hospital West Campus, a community hospital in suburban West Houston.  For more information on Texas Children's, go to www.texaschildrens.org. Get the latest news from Texas Children's by visiting the online newsroom and on Twitter at twitter.com/texaschildrens.

Contact:
Veronika Javor Romeis
Texas Children's Hospital
832-824-2157
vxjavor@texaschildrens.org


'/>"/>
SOURCE Texas Children's Hospital
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Austin Recovery Becomes Learning Environment for Texas A&M Health Science Center Medical Students
2. Texas Stop-Sale System Achieves Significant Results In Battle Against Meth
3. Texas Medicaid Managed-Care Problems Gaining National Attention
4. Softway Solutions Develops Award-Winning Health App for Texas Heart Institute
5. Texas A&M System Awarded National Center for Innovation
6. New Chronic Wound Therapy Awarded at Texas Largest Life Science Event
7. Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center Announce the Formation of the SRT University™ Comprehensive Education Series for Practitioners, Healthcare Professionals, and Patients
8. ECRI Institute Helps Hospitals Design Spaces for Current and Future Technologies
9. Luminex Corporation and University Hospital of Wales Collaborate During Olympic Games
10. Elekta Technology at Work in 100 Percent of Americas Top Cancer Hospitals
11. Survey: Hospital Executives Nationwide Facing Operating Room Case Volume Increases, Seeking Greater Efficiency through Healthcare Information Technology (HIT)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 27, 2016 , ... Quality metrics are proliferating in cancer care, and are ... the eye of the beholder, according to experts who offered insights and commentary in ... Managed Care. For the full issue, click here . , For the American ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):